Trial Profile
Efficacy and safety of enoxaparin sodium formulated by Eurofarma versus Sanofi-Aventis (Lovenox) in patients who have undergone major abdominal surgery
Status:
Completed
Phase of Trial:
Phase III
Latest Information Update: 12 Feb 2013
Price :
$35
*
At a glance
- Drugs Enoxaparin sodium (Primary)
- Indications Venous thromboembolism
- Focus Adverse reactions; Therapeutic Use
- 12 Feb 2013 New trial record